Literature DB >> 15131164

High seroprevalence of human T-cell lymphotropic virus type 1 in blood donors in Guyana and molecular and phylogenetic analysis of new strains in the Guyana shelf (Guyana, Suriname, and French Guiana).

Jean-François Pouliquen1, Lynette Hardy, Anne Lavergne, Eric Kafiludine, Mirdad Kazanji.   

Abstract

The prevalence of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 in blood donors in Guyana has never been estimated. We evaluated the prevalence of these viruses in blood donors by enzyme-linked immunosorbent assay and Western blotting and showed a prevalence of HTLV-1 of 1.3%; no HTLV-2 was detected. Female donors had a much higher HTLV-1 seroprevalence (3.6%) than male donors (0.7%). HTLV-1-seropositive donors tended to be slightly older than the average age for the total pool of donors. We also investigated the phylogenetic and molecular characteristics of HTLV-1 strains in Guyana and compared them with those identified in Suriname and French Guiana. Analysis of portions of the env and long terminal repeat nucleotide sequences showed that all the strains in Guyana and Suriname, like those in French Guiana, belonged to the transcontinental group of cosmopolitan subtype A. The similarities were greater between strains from Suriname and Guyana than between strains from Suriname and Guyana and those from French Guiana. Nevertheless, our results confirm that the HTLV-1 strains in all three countries have a common African origin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15131164      PMCID: PMC404635          DOI: 10.1128/JCM.42.5.2020-2026.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  49 in total

1.  Evidence among blood donors for a 30-year-old epidemic of human T lymphotropic virus type II infection in the United States.

Authors:  E L Murphy; K Watanabe; C C Nass; H Ownby; A Williams; G Nemo
Journal:  J Infect Dis       Date:  1999-12       Impact factor: 5.226

2.  Molecular epidemiology of HTLV-II among United States blood donors and intravenous drug users: an age-cohort effect for HTLV-II RFLP type aO.

Authors:  E L Murphy; R Mahieux; G de Thé; F Tekaia; D Ameti; J Horton; A Gessain
Journal:  Virology       Date:  1998-03-15       Impact factor: 3.616

3.  Evolutionary rate and genetic heterogeneity of human T-cell lymphotropic virus type II (HTLV-II) using isolates from European injecting drug users.

Authors:  M Salemi; A M Vandamme; C Gradozzi; K Van Laethem; E Cattaneo; G Taylor; C Casoli; P Goubau; J Desmyter; U Bertazzoni
Journal:  J Mol Evol       Date:  1998-05       Impact factor: 2.395

4.  HTLV-Is in Argentina are phylogenetically similar to those of other South American countries, but different from HTLV-Is in Africa.

Authors:  M Yamashita; G Picchio; R Veronesi; S Ohkura; P Bare; M Hayami
Journal:  J Med Virol       Date:  1998-06       Impact factor: 2.327

5.  Efficacy of donor screening for HTLV-I and the natural history of transfusion-transmitted infection.

Authors:  S Inaba; K Okochi; H Sato; K Fukada; N Kinukawa; H Nakata; K Kinjyo; F Fujii; Y Maeda
Journal:  Transfusion       Date:  1999-10       Impact factor: 3.157

6.  Seroindeterminate patterns and seroconversions to human T-lymphotropic virus type I positivity in blood donors from Martinique, French West Indies.

Authors:  R Césaire; O Bera; H Maier; A Lezin; J Martial; M Ouka; B Kerob-Bauchet; A K Ould Amar; J C Vernant
Journal:  Transfusion       Date:  1999-10       Impact factor: 3.157

7.  Seroepidemiological and molecular studies of human T cell lymphotropic virus type II, subtype b, in isolated groups of Mataco and Toba Indians of northern Argentina.

Authors:  M Biglione; O Vidan; R Mahieux; M de Colombo; M de los Angeles de Basualdo; M Bonnet; G Pankow; M A De Efron; A Zorrilla; F Tekaia; E Murphy; G de Thé; A Gessain
Journal:  AIDS Res Hum Retroviruses       Date:  1999-03-20       Impact factor: 2.205

Review 8.  Human T-lymphotropic virus type I infection.

Authors:  A Manns; M Hisada; L La Grenade
Journal:  Lancet       Date:  1999-06-05       Impact factor: 79.321

9.  Human T-lymphotropic virus type I among blood donors from Guadeloupe: donation, demographic, and biologic characteristics.

Authors:  F Rouet; C Foucher; M Rabier; I Gawronski; D Taverne; B Chancerel; O Casman; M Strobel
Journal:  Transfusion       Date:  1999-06       Impact factor: 3.157

10.  Evidence for a post-Columbian introduction of human T-cell lymphotropic virus [type I] [corrected] in Latin America.

Authors:  S Van Dooren; E Gotuzzo; M Salemi; D Watts; E Audenaert; S Duwe; H Ellerbrok; R Grassmann; E Hagelberg; J Desmyter; A M Vandamme
Journal:  J Gen Virol       Date:  1998-11       Impact factor: 3.891

View more
  8 in total

Review 1.  Clinical and Public Health Implications of Human T-Lymphotropic Virus Type 1 Infection.

Authors:  Nicolas Legrand; Skye McGregor; Rowena Bull; Sahar Bajis; Braulio Mark Valencia; Amrita Ronnachit; Lloyd Einsiedel; Antoine Gessain; John Kaldor; Marianne Martinello
Journal:  Clin Microbiol Rev       Date:  2022-02-23       Impact factor: 50.129

2.  New insights into prevalence, genetic diversity, and proviral load of human T-cell leukemia virus types 1 and 2 in pregnant women in Gabon in equatorial central Africa.

Authors:  Sonia Lekana-Douki Etenna; Mélanie Caron; Guillaume Besson; Maria Makuwa; Antoine Gessain; Antoine Mahé; Mirdad Kazanji
Journal:  J Clin Microbiol       Date:  2008-09-24       Impact factor: 5.948

3.  Adult T-cell leukemia/lymphoma incidence rate in French Guiana: a prospective cohort of women infected with HTLV-1.

Authors:  Jill-Léa Ramassamy; Patricia Tortevoye; Balthazar Ntab; Béatrice Seve; Gabriel Carles; Dominique Gaquière; Yoann Madec; Arnaud Fontanet; Antoine Gessain
Journal:  Blood Adv       Date:  2020-05-12

4.  Epidemiological Aspects and World Distribution of HTLV-1 Infection.

Authors:  Antoine Gessain; Olivier Cassar
Journal:  Front Microbiol       Date:  2012-11-15       Impact factor: 5.640

5.  Adult T-cell leukemia: a review of epidemiological evidence.

Authors:  Masako Iwanaga; Toshiki Watanabe; Kazunari Yamaguchi
Journal:  Front Microbiol       Date:  2012-09-10       Impact factor: 5.640

6.  High prevalence of human T-lymphotropic virus infection in indigenous women from the peruvian Amazon.

Authors:  Magaly M Blas; Isaac E Alva; Patricia J García; Cesar Cárcamo; Silvia M Montano; Nicanor Mori; Ricardo Muñante; Joseph R Zunt
Journal:  PLoS One       Date:  2013-09-05       Impact factor: 3.240

7.  Revisiting human T-cell lymphotropic virus types 1 and 2 infections among rural population in Gabon, central Africa thirty years after the first analysis.

Authors:  Melanie Caron; Guillaume Besson; Cindy Padilla; Maria Makuwa; Dieudonne Nkoghe; Eric Leroy; Mirdad Kazanji
Journal:  PLoS Negl Trop Dis       Date:  2018-10-25

8.  HTLV-1/2 prevalence in two Amazonian communities.

Authors:  Elida Cg Mata; Roberto M Bezerra; Aldo A Proietti Júnior; Luana Ks Pamplona; Lilian O Gomes; Valmir C Corrêa; Jordan Sr Caluff; Geanny S Borges; J Casseb; Lib Kanzaki
Journal:  J Virus Erad       Date:  2018-07-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.